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Objectives: To investigate the prevalence of metallo-b-lactamases (MBLs) and Tn6001 in carbapenem-
non-susceptible Pseudomonas aeruginosa (CNSPA). The CNSPA included extensively drug-resistant
P. aeruginosa (XDRPA) and non-XDRPA isolates in Taiwan.
Methods: A total of 308 CNSPA isolates collected at a medical centre from 2000 to 2005 and 26 XDRPA
collected from six medical centres in different regions of Taiwan in 2003 were included. MBL genes
and Tn6001 were detected by PCR. Clonal relatedness was determined by PFGE.
Results: Of the 308 CNSPA isolates, 30 (10%) were XDRPA, including 27 (9%) colistin-only-susceptible
(COS) and 3 (1%) colistin-only-intermediate (COI) P. aeruginosa. blaVIM-3 was found in 16 (53%) isolates
of the XDRPA (n530), whereas only 72 (26%) of the non-XDRPA (n5278) carried the gene. In450 was
higher in COS P. aeruginosa (12/27; 44%) than in non-XDRPA isolates (53/278; 19%). Tn6001 was
highest in COS P. aeruginosa (11/27; 41%), followed by COI P. aeruginosa (1/3; 33%), and
lowest in non-XDRPA (46/278; 17%). Of 26 XDRPA from six medical centres, higher prevalences of
blaVIM-3 (16/26; 62%), In450 (16/26; 62%) and Tn6001 (12/26; 46%) were found. Genotyping by PFGE
revealed 60 pulsotypes. Hybridization of a blaVIM-3-speciﬁc probe following PFGE suggested that the
mobile element Tn6001 might have transferred horizontally.
Conclusions:T n 6001 and In450 play an important role in the dissemination of CNSPA and XDRPA. The
prevalence of these genetic constituents was higher in XDRPA than in non-XDRPA isolates,
suggesting that the mobile element Tn6001 might have transferred horizontally.
Keywords: carbapenem-non-susceptible Pseudomonas aeruginosa (CNSPA), extensively drug-resistant
P. aeruginosa (XDRPA), metallo-b-lactamases
Introduction
Carbapenem resistance in Pseudomonas aeruginosa has become
more common in many countries and is correlated with multidrug
resistance (MDR). It is known that carbapenem resistance in
P. aeruginosa is usually associated with decreased permeability,
efﬂux pump up-regulation and/or the production of metallo-
b-lactamases (MBLs).
1–3 Different types of MBL have been
identiﬁed, including IMP, VIM, GIM, SIM and SPM.
2,3 The
VIM-3 MBL was ﬁrst reported in Taiwan in 2001 and was later
found on gene cassettes of the class 1 integron.
1,4,5,7 Recently, we
reported a transposon, Tn6001, which contains a blaVIM-3-
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cited.harbouring integron In450, in a clinical isolate of extensively
drug-resistant (XDR) P. aeruginosa (XDRPA).
6 However, the
overall prevalence of In450 and Tn6001 in VIM-3-carrying
carbapenem-non-susceptible P. aeruginosa (CNSPA) is unknown.
Materials and methods
Bacterial isolates
The 308 non-duplicate CNSPA isolates, deﬁned as isolates resistant
to imipenem or meropenem, were collected from 2000 to 2005 at
the National Taiwan University Hospital (NTUH), a 2500 bed
medical centre in northern Taiwan. If more than one isolate of
CNSPA was recovered from the same patient, only the ﬁrst isolate
was included. One of the 308 isolates, NTUH-PA450, was pre-
viously reported to carry a transposon Tn6001.
6 Colistin-only-
susceptible (COS) P. aeruginosa was deﬁned as resistance to all
antibiotics except colistin (MICs of colistin,  2 mg/L) and
colistin-only-intermediate (COI) P. aeruginosa was deﬁned as resist-
ance to all antibiotics with intermediate resistance to colistin (MIC
of colistin, 4 mg/L). The 26 XDRPA isolates were collected in 2003
from six medical centres located in different regions of Taiwan.
5
Antimicrobial susceptibility testing
MICs of nine antimicrobial agents were determined using an agar
dilution method according to CLSI guidelines.
8 The following anti-
microbial agents were provided by their manufacturers for use in
this study: piperacillin/tazobactam, ceftazidime, cefepime, aztreo-
nam, amikacin, ciproﬂoxacin, imipenem, meropenem and colistin.
XDRPA was deﬁned as P. aeruginosa isolates resistant to antimicro-
bial agents piperacillin/tazobactam, ceftazidime, cefepime, aztreo-
nam, amikacin, ciproﬂoxacin, imipenem and meropenem, and
susceptible or intermediately resistant to colistin.
Detection of MBL genes by PCR ampliﬁcation
and sequencing
PCR ampliﬁcation of MBL genes, including blaIMP-1-9, blaVIM-1 and
blaVIM-2 genes, was performed according to previously reported pro-
tocols [Table S1, available as Supplementary data at JAC Online
(http://jac.oxfordjournals.org/)].
4,9 The types of MBL were con-
ﬁrmed by sequence.
Detection of Tn6001 and blaVIM-2-harbouring integron
cassette by multiplex PCR
The dissemination of Tn6001 in clinical isolates was detected by mul-
tiplex PCR (the primers are listed in Table S1) targeting the junctions
of the In450 and Tn6001 backbone structure (GenBank accession
number EF138817). The amplicon sizes and locations are shown in
Figure 1(a). The blaVIM-2-harbouring integron cassette was detected
by two sets of PCR (Figure 1b) and conﬁrmed by sequencing.
Genotyping by PFGE
Genotypes of 109 of the 308 CNSPA isolates (30 isolates of
XDRPA, including 27 COS P. aeruginosa and 3 COI P. aeruginosa,
and 79 blaVIM-2 and blaVIM-3-producing non-XDR CNSPA) from
NTUH and 26 XDRPA from six medical centres were determined
by PFGE. PFGE analysis was carried out as described previously.
1
Southern blot hybridization
The SpeI-digested chromosome fragments of four clinical isolates
were analysed by PFGE. The PFGE gel was then subjected
to Southern blotting and hybridized with a DIG (digoxigenin)-
labelled blaVIM-3-speciﬁc probe. The hybridization assay was per-
formed as described previously.
10
Results
Antimicrobial susceptibility of CNSPA isolates from NTUH
A high percentage of cross-resistance to ceftazidime (66%–89%)
and cefepime (63%–90%) was found in the CNSPA isolates
[Table S2, available as Supplementary data at JAC Online (http://
jac.oxfordjournals.org/)]. The rate of resistance to monobactam
(aztreonam) was also high (52%–90%). It is noted that resistance
to ciproﬂoxacin increased quickly from 2002 to 2004 (76%–
93%) while resistance to amikacin ranged from 24% to 56% and
there was no resistance to colistin noted in these isolates.
Difﬁculty in treating COS and COI P. aeruginosa was found from
2003 to 2005, but the percentages (11%–19% and 0%–3%,
respectively) were low. Neither a signiﬁcant increase in the preva-
lence of COS or COI P. aeruginosa nor shifts of resistance to cat-
egories of medically useful antibiotics were noted.
Distribution of MBL genes, integron cassette and Tn6001
blaVIM-2 and blaVIM-3 genes were detected in 6 (1.9%) and 88
(28.6%) of the 308 CNSPA from NTUH. The prevalence of the
blaVIM-3 gene ranged from 13% to 32% in non-XDRPA isolates
collected during 2000–05 except in 2002. The prevalence of the
blaVIM-3 gene was exceptionally high (52%) in 2002 (Table 1).
COS and COI P. aeruginosa were ﬁrst isolated in 2003 and per-
sisted in 2004 and 2005. Furthermore, signiﬁcant increases in
VIM-3 (40% to 67%), In450 (40% to 56%) and Tn6001 (40%
to 50%) from 2003 to 2005 were also noted among COS iso-
lates. Six CNSPA carried a blaVIM-2-harbouring integron cas-
sette (Figure 1b). Of these integrons, four were identical to
AY943084, whereas two (04-14 and 05-43) contained different
types of blaVIM-2-harbouring integron.
blaVIM-2 and blaVIM-3 genes were detected in 4 (15.4%) and
16 (61.5%) of the 26 XDRPA isolates collected from six
medical centres in Taiwan. Twenty-ﬁve (96%) were COS and
only one (4%) was COI [Table S3, available as Supplementary
data at JAC Online (http://jac.oxfordjournals.org/)]. Neither
In450 nor Tn6001 was found in the COI isolate. High percen-
tages of In450 and Tn6001 [100% (11/11) and 64% (7/11),
respectively] were detected in COS isolates from hospital N1.
Similar high percentages (4/10, 40%) were also noted in hospital
N2. These ﬁndings suggest that the high prevalences of In450
and Tn6001 are associated with MDR P. aeruginosa in Taiwan.
PFGE analysis
PFGE analysis of the 135 P. aeruginosa isolates revealed 60
different pulsotypes. There were 51 different pulsotypes found
in 109 CNSPA isolates from NTUH and 16 from 26 XDRPA
from six medical centres (seven pulsotypes were distributed
among isolates from both NTUH and six medical centres). Four
of 15 pulsotypes from the 30 XDRPA isolates and 18 of 49 pul-
sotypes from 79 non-XDR CNSPA from NTUH and 5 of 16
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tiple isolates ( 2 isolates).
Structures of two variants of In450
Two variant structures of In450 were found in three non-XDRPA
isolates. One integron cassette, designated In450.1, contained the
following seven genes: blaVIM-3, orf2, three copies of aacA4,
aadB and a copy of aacA4. The other integron cassette,
designated In450.2, contained the following ﬁve genes: blaVIM-3,
orf2, aacA4, aadB and a copy of aacA4 (Figure 1a). Both In450.1
and In450.2 were harboured in the Tn6001 backbone structure,
designated Tn6001.1 and Tn6001.2, respectively (Figure 1a).
Mobile DNA Tn6001
Although it was difﬁcult to demonstrate that gene transfer had
occurred in the MDR isolate, the results from two closely
Figure 1. (a) Genetic organization of transposons Tn6001,T n 6001.1 and Tn6001.2 in P. aeruginosa isolates. Genes are shown as arrows, with their
orientation of transcription indicated by the arrowheads. A4, aacA4 gene. The sizes and location of the multiplex PCR amplicons are displayed in Tn6001.
IRi, left-hand integron inverted repeat (25 bp); IRt, right-hand integron inverted repeat (25 bp); TIRL: left-hand transposon inverted repeat; f-TIRR: potential
right-hand transposon inverted repeat. (b) Three different blaVIM-2-harbouring integron cassettes were ampliﬁed by two primer sets.
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of Tn6001. In patient A, an imipenem-susceptible isolate (MIC,
0.12 mg/L) recovered 3 months before the isolation of the
carbapenem-resistant isolate (MIC, .32 mg/L) was used for
comparison. PFGE/hybridization analysis revealed only a one
band difference between these two isolates [Figure S1a, lanes 1
and 2, available as Supplementary data at JAC Online (http://
jac.oxfordjournals.org/)]. This DNA fragment contained the
blaVIM-3 gene, which was associated with imipenem resistance
(Figure S1b, lanes 1 and 2). Furthermore, this imipenem-
resistant isolate showed the presence of Tn6001 by multiplex
PCR. These ﬁndings indicate that the second clinical isolate
developed its imipenem resistance phenotype through DNA
acquisition and was probably transferred by transposon.
Discussion
Consistent with previous studies, the blaVIM-3 gene was the most
common MBL gene in MBL-producing P. aeruginosa isolates in
Taiwan and was usually harboured by class 1 integrons.
1,4,5 The
prevalence of blaVIM-3 in COI or COS P. aeruginosa was higher
than that in non-XDRPA isolates. Higher prevalences of In450
and Tn6001 were also detected in COI and COS isolates, both
from NTUH and from the six hospitals located in various areas
in Taiwan (Tables 1 and S3). These ﬁndings indicate that In450
and Tn6001 may account for the transfer of drug resistance
genes. However, other mechanisms may also play a role. Since
as high as 52% (11/21) of CNSPA contained blaVIM-3 in 2002,
but only a disproportionately low percentage (24%, 5/21) of
them carried In450 and 14% (3/21) carried Tn6001. These
results suggest that unknown mechanisms other than In450 and
Tn6001 may be responsible for the spread of blaVIM-3.
Tn6001 was found in different pulsotypes of P. aeruginosa
isolates. Although it is difﬁcult to demonstrate the gene transfer
property of Tn6001 in the laboratory, results from this study still
provide two pieces of evidence supporting the possibility that
Tn6001 is a mobile DNA element and thus disseminated among
different isolates. First, the ﬁnding that there was only one band
difference identiﬁed by PFGE and hybridization with a
blaVIM-3-speciﬁc probe may suggest that Tn6001 could be
acquired by a susceptible isolate and thus become resistant
(Figure S1). Second, the heterogeneity of pulsotypes for
Tn6001-containing P. aeruginosa isolates revealed polyclonal
relatedness, suggesting that horizontal transfer may have
occurred. However, several isolates recovered from NTUH
(2000–05) and six medical centres (2003) exhibited identical
pulsotypes and contained Tn6001 suggesting the presence of
intra-hospital and inter-hospital clonal dissemination.
In addition, Yan et al.
5 described that after digestion with
EcoRI in MDR P. aeruginosa isolates, there were three different
DNA fragments (6.2, 6.6 and 8.8 kb) found with a blaVIM-3-
speciﬁc probe. These isolates all contained Tn6001 and one EcoRI
site (position 5942 of GenBank accession number EF138817),
which was located at orf2 downstream of blaVIM-3.T h i sﬁ n d i n g
suggested that the three different patterns of EcoRI-digested DNA
fragments found by Yan et al.
5 were due to different locations of
Tn6001 integration. These inferences suggest that the distribution
of Tn6001 might be associated with horizontal transfer.
Table 1. Prevalence of VIM-3, In450 and Tn6001 in 308 CNSPA isolates at NTUH from 2000
to 2005
Year (CNSPA isolates) Isolates (no.)
No. (%) of isolates
VIM-3 In450 Tn6001
2000 (n¼60) non-XDR
a (n¼60) 10 (17) 8 (13) 5 (8)
2001 (n¼41) non-XDR
a (n¼41) 13 (32) 9 (23) 9 (23)
2002 (n¼21) non-XDR
a (n¼21) 11 (52) 5 (24) 3 (14)
2003 (n¼63) non-XDR
a (n¼50) 16 (32) 12 (24)
d 12 (24)
d
XDR
COS
b (n¼12) 4 (40) 4 (40) 4 (40)
COI
c (n¼1) 1 (100) 0 (0) 0 (0)
2004 (n¼70) non-XDR
a (n¼59) 16 (27) 14 (24) 13 (22)
XDR
COS
b (n¼9) 5 (56) 5 (56) 4 (44)
COI
c (n¼2) 2 (100) 1 (50) 1 (50)
2005 (n¼53) non-XDR
a (n¼47) 6 (13) 5 (11)
e 4 (9)
f
XDR
COS
b (n¼6) 4 (67) 3 (50) 3 (50)
Total (n¼308) 88 (29) 66 (21) 58 (19)
aNon-XDR, non-COS and non-COI.
bCOS, colistin-only-susceptible, resistant to all antibiotics except colistin.
cCOI, colistin-only-intermediate, resistant to all antibiotics except intermediate to colistin.
dIn450.1 (n¼1) and Tn6001.1 (n¼1) were found in the same clinical isolate.
eIn450.1 (n¼1) and In450.2 (n¼1) were found in two clinical isolates.
fTn6001.1 (n¼1) and Tn6001.2 (n¼1) were found in two clinical isolates.
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isms other than Tn6001 dissemination. A high percentage of
aztreonam resistance could be correlated with blaOXA-10 and
blaOXA-17 spreading,
5 whereas ﬂuoroquinolone resistance has
been linked to amino acid changes in topoisomerase types II and
IV. We also found that mutations in GyrA (Thr-83!Ile) and
ParC (Ser-87!Leu) in the quinolone resistance-determining
region may be associated with quinolone resistance (data not
shown). Thus, further characterization of XDRPA isolates is a
priority and an important issue in Taiwan.
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